TriSalus Life Sciences
TLSI
TLSI
28 hedge funds and large institutions have $9.21M invested in TriSalus Life Sciences in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
Holders
28
Holders Change
+2
Holders Change %
+7.69%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| $110 | -$58K | -10,539 | -100% |
|
|
CS
27
Clear Street
New York
| $6 | – | – | – |
|
|
DM
28
Deerfield Management
New York
| $6 | – | – | – |
|
|
LNWWM
29
Laird Norton Wetherby Wealth Management
San Francisco,
California
| – | -$341K | -34,950 | Closed |
|
|
TWP
30
Tyche Wealth Partners
Plano,
Texas
| – | -$97.5K | -10,000 | Closed |
|
31
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$53.5K | -5,490 | Closed |
|
32
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$3 | -291 | Closed |
|